1P-MIPLA

1P-MIPLA
Clinical data
Other names1-Propanoyl-lysergic acid methylisopropylamide; 1-Propanoyl-MIPLA; N,6-Dimethyl-1-propanoyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-N,7-dimethyl-4-propanoyl-N-(propan-2-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
PubChem CID
ChemSpider
Chemical and physical data
FormulaC23H29N3O2
Molar mass379.504 g·mol−1
3D model (JSmol)
  • CCC(=O)n1cc2c3c1cccc3C1=C[C@H](CN([C@@H]1C2)C)C(=O)N(C(C)C)C
  • InChI=1S/C23H29N3O2/c1-6-21(27)26-13-15-11-20-18(17-8-7-9-19(26)22(15)17)10-16(12-24(20)4)23(28)25(5)14(2)3/h7-10,13-14,16,20H,6,11-12H2,1-5H3/t16-,20-/m1/s1
  • Key:ISWISZIALPXJJD-OXQOHEQNSA-N

1P-MIPLA, also known as 1-propanoyl-lysergic acid methylisopropylamide (1-propanoyl-MIPLA), is a designer drug and presumed serotonergic psychedelic of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2][3] It is the 1-propanoyl derivative of MIPLA and may act as a prodrug of MIPLA.[1][2][3] 1P-MIPLA has been discussed on specialized online forums since 2018.[1] In addition, a designer drug product labeled "1P-MIPLA" but actually containing MIPLA was encountered in Austria in 2019.[1]

See also

References

  1. ^ a b c d "1P-MiPLA". АИПСИН (AIPSIN) (in Russian). Retrieved 1 July 2025.
  2. ^ a b Tusiewicz K, Wachełko O, Zawadzki M, Szpot P (December 2024). "Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy". Molecules. 29 (23). Basel, Switzerland: 5717. doi:10.3390/molecules29235717. PMC 11643092. PMID 39683876.
  3. ^ a b Wachełko O, Nowak K, Tusiewicz K, Zawadzki M, Szpot P (2025). "A highly sensitive UHPLC-MS/MS method for determining 15 designer LSD analogs in biological samples with application to stability studies". The Analyst. 150 (2): 290–308. Bibcode:2025Ana...150..290W. doi:10.1039/D4AN01361A. ISSN 0003-2654. PMID 39636448. Retrieved 1 July 2025.



This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.